אוקסליפלטין "אבווה" 150 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXALIPLATIN 150 MG/VIAL
Available from:
PHARMALOGIC LTD
ATC code:
L01XA03
Pharmaceutical form:
POWDER FOR CONCENTRATE FOR INFUSION
Administration route:
I.V
Manufactured by:
EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA
Therapeutic group:
OXALIPLATIN
Therapeutic indications:
Oxaliplatin in combination with 5- fluorouracil and folinic acid (FA) is indicated for : * adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour * treatment of advanced colorectal cancer.
Authorization date:
2009-05-01
